FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes a novel agent and pharmaceutical composition on its base for inhibition of tumor cells growth in patient. Invention proposes new analogs of acylfulven of the formula (I) where R means (a) and R1 means alkyl, aryl, NH2, NHR or NR2. Agent and pharmaceutical composition based on said are able to inhibit the growth of tumor cells without excessive toxicity for patient. EFFECT: valuable antitumor activity of analogs. 10 cl, 11 tbl, 11 dwg, 13 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUND ANTAGONIST VEGF AND ANTIPROLIFERATIVE AGENT | 2004 |
|
RU2353353C2 |
METHOD FOR TREATING NEURODEGENERATIVE DISORDER OR MYELINOGENESIS DISORDER | 1997 |
|
RU2266129C2 |
DIARYLTHIOHYDATOIC COMPOUNDS | 2007 |
|
RU2449993C2 |
DERIVATIVES OF BENZOFURAZANE OR BENZO-2,1,3-THIADIAZOLE AND METHOD OF TREATMENT | 1998 |
|
RU2189984C2 |
FACTOR EFFECTING ON ACTIVITY OF TUMOR NECROSIS FACTOR RECEPTOR-RELEASING ENZYME | 1999 |
|
RU2279478C2 |
SPIRO OXINDOLE MDM2 ANTAGONISTS | 2010 |
|
RU2553269C2 |
BENZOXAZINE COMPOUNDS FOR ENHANCING SYNAPTIC RESPONSE | 1998 |
|
RU2246497C2 |
METHOD FOR NEUROPATHIC PAIN RELIEF USING PEPTIDES AS DERIVATIVES OF PROSAPOSIN | 1997 |
|
RU2223969C2 |
METHODS AND MATERIALS FOR PRODUCING SIMVASTATIN AND RELATED COMPOUNDS | 2007 |
|
RU2447152C2 |
MACROCYCLIC COMPOUNDS, APPLIED AS HISTONE DEACETYLASE INHIBITORS | 2011 |
|
RU2565076C2 |
Authors
Dates
2000-02-27—Published
1994-02-02—Filed